Clark Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$662K Sell
5,121
-168
-3% -$19.7K 0.37% 43
2026
Q1
$641K Buy
5,289
+491
+10% +$56.7K 0.43% 34
2025
Q4
$505K Hold
4,798
0.31% 41
2025
Q3
$505K Sell
4,798
-1,542
-24% -$127K 0.31% 41
2025
Q2
$502K Buy
6,340
+109
+2% +$8.66K 0.34% 38
2025
Q1
$559K Buy
6,231
+350
+6% +$32.7K 0.41% 35
2024
Q4
$585K Buy
+5,881
New +$606K 0.45% 33

Other funds holding MRK

Clark Wealth Partners's MRK Position: Q2 2026 in Review

Clark Wealth Partners reduced its Merck (MRK) stake by 3.2% in Q2 2026, selling an estimated $19.7K and leaving 5,121 shares worth $662K. The position accounts for 0.37% of the portfolio, ranked #43.

Clark Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,688 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Clark Wealth Partners held 5,121 shares of Merck worth $662K as of Q2 2026.
  • Clark Wealth Partners sold 168 Merck shares in Q2 2026, an estimated $19.7K.
  • Merck made up 0.37% of Clark Wealth Partners's portfolio in Q2 2026, its #43 holding.
  • Clark Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,688 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Clark Wealth Partners's 13F filing for Q2 2026, filed 28 Jul 2026.